The Department of Immunology and Medicine's missions are to support medical product development to protect the war fighter, and conduct surveillance of diseases of military importance in SE Asia. Our focus on diseases of relevance to the public health means that our mission is integrated with the public health efforts of our host nation partners.
Our Sponsors include
- Organizations within the US Army Medical Research and Materiel Command
- Other Department of Defense and US Government Organizations
- Extramural Collaborators – host nation governments, NGOs, industry and academia
Key elements of our mission include:
A. Antimalarial product development
The US Army is currently developing the following products for FDA licensure.
- Drugs: we seek new drugs to prevent malaria. There is very little development of new drugs for prevention currently, and resistance threatens existing drugs
- Vaccines: we seek to develop vaccines to protect against P. falciparum and P. vivax.
B. Disease Surveillance. Our public health surveillance efforts focus on:
- Antimalarial drug resistance
- Influenza surveillance
- Surveillance for other pathogens causing influenza-like illness (ILI)
- Emerging infectious disease
- GMP-formulated intravenous artesunate for severe malaria
- Tafenoquine for weekly antimalarial chemoprophylaxis
- A malaria vaccine. The US Army helped discover and develop the RTS,S vaccine, and has tested numerous candidates in recent years.
| Our Mission | News | History | Our Values | Our Approach | Our Assets | Our Research |
to AFRIMS main page